换一批
换一批CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models.
第一作者：
Masashi,Chonan
第一单位：
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan (M.C., R.S., T.S., I.S., M.K., Y.S., T.T.); Pathological Division, Tohoku University Hospital, Sendai, Japan (M.W.); Departments of Respiratory Oncology and Molecular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (T.K.); Department of Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan (N.I.).
作者：
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);动物(Animals);脑肿瘤(Brain Neoplasms);CD40配体(CD40 Ligand);癌症疫苗(Cancer Vaccines);儿童(Child);疾病模型, 动物(Disease Models, Animal);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);胶质母细胞瘤(Glioblastoma);人类(Humans);免疫组织化学(Immunohistochemistry);免疫疗法(Immunotherapy);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);中年人(Middle Aged);预后(Prognosis);受体, OX40(Receptors, OX40);青年人(Young Adult)
DOI
10.1093/neuonc/nov090
PMID
26008605
发布时间
2018-11-13
- 浏览39
Neuro-oncology
1453-62页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
